Published in Medical Verdicts and Law Weekly, October 28th, 2004
This collaboration will bring together a rich portfolio of expertise in the area of antibody discovery, development and manufacturing. BioInvent will contribute its knowledge and experience in antibody discovery, production and immunology.
ThromboGenics will contribute its research and clinical development skills in the area of vascular medicine. Both parties will provide core intellectual property based on specific therapeutic targets.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.